Results 21 to 30 of about 2,127,841 (292)

Introduction to Interpersonal Acceptance-Rejection Theory (IPARTheory) and Evidence [PDF]

, 2021
Interpersonal acceptance-rejection theory (IPARTheory) is an evidence-based theory of socialization and lifespan development. It is composed of three subtheories, each of which deals with a separate but interrelated set of issues.
Rohner, Ronald P., Ronald P. Rohner
core   +1 more source

Prognostic factors for the evolution and reversibility of chronic rejection in pediatric liver transplantation

Clinics, 2016
OBJECTIVE: Chronic rejection remains a major cause of graft failure with indication for re-transplantation. The incidence of chronic rejection remains high in the pediatric population.
Ana Cristina Aoun Tannuri, Fabiana Lima, Evandro Sobroza de Mello, Ryan Yukimatsu Tanigawa, Uenis Tannuri   +4 more
doaj   +1 more source

Chronic rejection occurring early post liver transplant

Indian Journal of Transplantation, 2023
We report the case of a 36-year-old male who was referred to us with a provisional diagnosis of ethanol-related acute on chronic liver failure with ascites, encephalopathy, and altered liver function tests (LFTs).
Nalini Bansal, Arif Ali Khan, Manav Wadhawan, Vivek Vij   +3 more
doaj   +1 more source

Hand disease in scleroderma: a clinical correlate for chronic hand transplant rejection [PDF]

, 2013
Chronic rejection remains a potential long-term consequence of hand composite tissue allotransplantation (CTA). Scleroderma has already been proposed as a model for chronic facial allograft rejection based on potential parallels of observed progression ...
Puri, A, Butler, PE, Clarke, A, Amin, K; id_orcid, Amin, K, Sivakumar, B, Denton, C   +6 more
core   +1 more source

Acute rejection on immune-mediated chronic rejection after liver transplantation

, 2021
Rejection is frequent after liver transplantation (LT). Pathogenesis of acute cellular rejection (ACR) is attributable to recipient Tcells; chronic rejection (CR) has a multifactorial pathogenesis.
TAVANO D., MENNINI G., D'AMBROSIO D., DEVILLEDEGOYET J., MITTERHOFER A. P., ROSSI M., FRAMARINODEIMALATESTA M., CORSI A., GINANNICORRADINI S., MERLI M., LATTANZI B., MITTERHOFER, ANNA PAOLA, Daria D’AMBROSIO, Anna Paola MITTERHOFER, Stefano GINANNI CORRADINI, Barbara LATTANZI, Daniele TAVANO, Alessandro CORSI, Gianluca MENNINI, Manuela MERLI, Jean DE VILLE DE GOYET, Massimo ROSSI, Marialuisa FRAMARINO DEI MALATESTA   +22 more
core   +2 more sources

A comparative histological analysis of early and late graft dysfunction in different time zones following living donor liver transplantation

Indian Journal of Pathology and Microbiology, 2022
Background: Liver biopsy plays a crucial role in evaluating allograft dysfunction. Comprehensive analysis of the histological spectrum of complications, particularly rejection, in different time zones is lacking.
Archana Rastogi, Nayana Patil, Sphurti Srivastava, Gayatri Ramakrishna, Rakhi Maiwal, Guresh Kumar, Ashok K Choudhary, Seema Alam, Chhagan Bihari, Viniyendra Pamecha   +9 more
doaj   +1 more source

IL-21 Receptor Blockade Shifts the Follicular T Cell Balance and Reduces De Novo Donor-Specific Antibody Generation

Frontiers in Immunology, 2021
Donor-specific antibodies (DSAs) play a key role in chronic kidney allograft injury. Follicular T helper (Tfh) cells trigger the humoral alloimmune response and promote DSA generation, while T-follicular regulatory (Tfr) cells inhibit antibody production
Yeqi Nian, Yeqi Nian, Yeqi Nian, Yeqi Nian, Zhilei Xiong, Panpan Zhan, Panpan Zhan, Panpan Zhan, Zhen Wang, Yang Xu, Jianghao Wei, Jie Zhao, Jie Zhao, Jie Zhao, Jie Zhao, Yingxin Fu, Yingxin Fu, Yingxin Fu, Yingxin Fu   +18 more
doaj   +1 more source

Reduced CD40L expression on ex vivo activated CD4+T-lymphocytes from patients with excellent renal allograft function measured with a rapid whole blood flow cytometry procedure [PDF]

, 2004
Background: The CD40-CD40L (CD154) costimulatory pathway plays a critical role in the pathogenesis of kidney allograft rejection. In renal transplant biopsies, CD4+ CD40L+ graft-infiltrating cells were detected during chronic rejection in contrast to ...
Lederer, Stephan R., Sitter, Thomas, Toepfer, Marcel, Gruber, R., Landgraf, R., Friedrich, N.   +5 more
core   +1 more source

Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres

Frontiers in Immunology, 2020
Alemtuzumab, a monoclonal antibody targeting CD52 that causes lymphocyte apoptosis, is a form of advanced immunosuppression that is currently used as a therapy for refractory acute cellular rejection and chronic lung allograft dysfunction in lung ...
Anil J. Trindade, Anil J. Trindade, Anil J. Trindade, Tany Thaniyavarn, Tany Thaniyavarn, Keri Townsend, Robin Klasek, Karen P. Tsveybel, John C. Kennedy, John C. Kennedy, Hilary J. Goldberg, Hilary J. Goldberg, Souheil El-Chemaly, Souheil El-Chemaly   +13 more
doaj   +1 more source

Chronic rejection. [PDF]

Journal of the American Society of Nephrology, 1994
Current immunosuppressive protocols have significantly decreased graft loss to acute rejection but have had no effect on graft loss to chronic rejection. Recently, attention has been focused on the prevention and management of chronic rejection. Centers must come to a uniform definition of this phenomenon so that studies can be compared. It is believed
A J, Matas, J F, Burke, G A, DeVault, A, Monaco, J D, Pirsch   +4 more
openaire   +2 more sources